<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
<channel>
<title>Pharma RSS Feed</title>
<link>http://industry.bnet.com/pharma/feed/rss/</link>
<atom:link href="http://industry.bnet.com/pharma/feed/rss/" rel="self" type="application/rss+xml" />
<description>BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.</description>
<category>Pharma</category>
<language>en-us</language>
<lastBuildDate>Tue, 24 Nov 2009 01:34:28 PST</lastBuildDate>
<ttl>720</ttl>
<item>
	<title><![CDATA[Merck - Vioxx: Adverse Heart Effects May Have Been Identified Years Earlier]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/merck-vioxx-adverse-heart-effects/21596/</link>
	<description><![CDATA[
	 CHICAGO – Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of  Archives of Internal...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/SQR0eUJjWfM/">Pharmalot</a> - Vioxx Risks Could Have Been Detected In 2000</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/merck-vioxx-adverse-heart-effects/21596/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Mon, 23 Nov 2009 14:16:00 PST</pubDate>
</item>
<item>
	<title><![CDATA["Fly paper" grabs cancer cells]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/fly-paper-grabs-cancer-cells/21551/</link>
	<description><![CDATA[
	UCLA researchers have developed a nano device that can capture circulating cancer cells (CTCs) in a patient's blood. These CTCs cause metastasis, the leading cause of death in patients with solid tumors. The new nano "fly paper" can grab cancer cells that have broken off from tumors, giving...
				<ul>
					<li><a class="source" href="http://www.theengineer.co.uk/Articles/Article.aspx?liArticleID=314204">The Engineer</a> - Chip captures circulating tumour cells</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/fly-paper-grabs-cancer-cells/21551/</guid>
	<dc:creator>FierceBioResearcher</dc:creator>
	<pubDate>Thu, 19 Nov 2009 12:38:20 PST</pubDate>
</item>
<item>
	<title><![CDATA[Abu Dhabi building $150m biologics plant]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/abu-dhabi-building-150m-biologics/21489/</link>
	<description><![CDATA[
	The United Arab Emirates (UAE), which Abu Dhabi is part of, has made sizeable investments and offered incentives to boost its pharma industry, in part to diversify its industry beyond oil. Emirates Biotech Pharmaceutical Factory, a new company, will setup the facility to produce crystal insulin...
				<ul>
					<li><a class="source" href="http://www.fiercebiotech.com/story/uae-sets-150m-biologics-plant/2009-11-23?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0">FierceBiotech</a> - UAE sets up $150M biologics plant</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/abu-dhabi-building-150m-biologics/21489/</guid>
	<dc:creator>In-Pharma Technologist</dc:creator>
	<pubDate>Mon, 23 Nov 2009 02:00:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Sanofi's Viehbacher speaks]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/sanofis-viehbacher-speaks/21416/</link>
	<description><![CDATA[
	In a veiled swipe at Gerard Le Fur, his predecessor and former head of research and development, who was appointed chief executive and ousted within months, he said: “We had really a scientific organisation that really lived within its own walls; not a lot of external partnerships, virtually no...
				<ul>
					<li><a class="source" href="http://traxfer.ft.com/cms/s/0/d461b6ac-d790-11de-b578-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticals">Financial Times</a> - Sanofi chief lays out distinctive strategy</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/sanofis-viehbacher-speaks/21416/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Sun, 22 Nov 2009 12:02:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Pfizer - Prempro: Kris Hundley writes]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/pfizer-prempro-kris-hundley/21269/</link>
	<description><![CDATA[
	 Is Prempro, the hormone drug known to increase the risk of breast cancer, a public hazard?  If a judge in Pinellas County determines that it is, hundreds of thousands of documents now under seal in lawsuits against the drug's manufacturer nationwide could be released for the public to inspect....
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/L1jemy1kpzA/">Pharmalot</a> - Secret Prempro Documents To Surface In Florida?</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/pfizer-prempro-kris-hundley/21269/</guid>
	<dc:creator>PharmaGossip</dc:creator>
	<pubDate>Fri, 20 Nov 2009 06:00:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Movetis plots European IPO]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/movetis-plots-european-ipo/21277/</link>
	<description><![CDATA[
	Belgian drugmaker Movetis said today that it will seek up to €112.4 ($167 million) in an upcoming IPO. The gastroenterology company--which was founded in 2006 as a spin-off Johnson & Johnson units Janssen and Ortho-McNeil--recently won European approval of its chronic constipation treatment...
				<ul>
					<li><a class="source" href="http://invivoblog.blogspot.com/2009/11/financings-of-fortnight-has-european.html">The In Vivo Blog</a> - Financings of the Fortnight Has European Flavor, Roadshow Fever</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/movetis-plots-european-ipo/21277/</guid>
	<dc:creator>FierceBiotech</dc:creator>
	<pubDate>Fri, 20 Nov 2009 05:30:23 PST</pubDate>
</item>
<item>
	<title><![CDATA[Julie Brill Nominated to FTC: A Message to Drug Manufacturers?]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/julie-brill-nominated-ftc-message/21149/</link>
	<description><![CDATA[
	The Obama administration may have sent a subtle message to drug manufacturers Monday, when it nominated Julie Brill to be one of two new commissioners at the Federal Trade Commission. The message? Make sure your marketing practices don’t collide with consumers’ best interests.Brill has...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/nauR90jH7zA/">Pharmalot</a> - Pharma Watchdog Nominated As An FTC Commish</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/julie-brill-nominated-ftc-message/21149/</guid>
	<dc:creator>The In Vivo Blog</dc:creator>
	<pubDate>Thu, 19 Nov 2009 10:38:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Judge: Send federal Seroquel suits to courts]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/judge-send-federal-seroquel-suits/21113/</link>
	<description><![CDATA[
	While AstraZeneca preps for its first Seroquel liability trials at the state level, federal lawsuits are coming closer to court as well. U.S. District Judge Anne Conway, who's overseeing pretrial work for thousands of federal Seroquel cases, said she will ask a panel of judges to send all those...
				<ul>
					<li><a class="source" href="http://pharmagossip.blogspot.com/2009/11/astrazeneca-seroquel-bring-it-on.html">PharmaGossip</a> - AstraZeneca - Seroquel: bring it on!</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/judge-send-federal-seroquel-suits/21113/</guid>
	<dc:creator>FiercePharma</dc:creator>
	<pubDate>Thu, 19 Nov 2009 07:49:15 PST</pubDate>
</item>
<item>
	<title><![CDATA[Ruling could remodel whistleblower world]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/ruling-remodel-whistleblower/21109/</link>
	<description><![CDATA[
	A federal appeals court has ruled that Cell Therapeutics can pursue a claim for nearly $23 million against a former consultant that advised it to market a drug off-label, adding a whole new wrinkle to whistleblower lawsuits. Report More information about formatting options
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/dhdtK3ob5sQ/">Pharmalot</a> - Biotech Can Sue Consultant Over Whistleblower Loss</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/ruling-remodel-whistleblower/21109/</guid>
	<dc:creator>FiercePharma</dc:creator>
	<pubDate>Thu, 19 Nov 2009 08:17:43 PST</pubDate>
</item>
<item>
	<title><![CDATA[AstraZeneca files Brilinta NDA]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/astrazeneca-files-brilinta-nda/21115/</link>
	<description><![CDATA[
	AstraZeneca today announced it has submitted an NDA to the FDA for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS). The proposed trade name for ticagrelor is Brilinta, pending approval...
				<ul>
					<li><a class="source" href="http://www.scripnews.com/home/AstraZeneca-files-Brilinta-in-the-US-181095">Scrip News</a> - AstraZeneca files Brilinta in the US</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/astrazeneca-files-brilinta-nda/21115/</guid>
	<dc:creator>FierceBiotech</dc:creator>
	<pubDate>Thu, 19 Nov 2009 06:36:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Hard to Get Excited about BI's Flibanserin]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/hard-excited-bis-flibanserin/20903/</link>
	<description><![CDATA[
	You might have missed the 12th Congress of the European Society for Sexual Medicine in Lyon, France, this week. If you did, US Phase III results for Boehringer Ingelheim's flibanserin might have passed you by, too. The drug--a serotonin 5-HT1A receptor agonist, 5-HT2A antagonist and partial...
				<ul>
					<li><a class="source" href="http://www.in-pharmatechnologist.com/Industry-Drivers/Failed-anti-depressant-flibanserin-reborn-as-female-Viagra?utm_source=RSS_text_news">In-Pharma Technologist</a> - Failed anti-depressant flibanserin reborn as female “Viagra”?</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/hard-excited-bis-flibanserin/20903/</guid>
	<dc:creator>The In Vivo Blog</dc:creator>
	<pubDate>Wed, 18 Nov 2009 06:00:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[Genzyme: Contents Under Pressure]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/genzyme-contents-pressure/20849/</link>
	<description><![CDATA[
	Friday's announcement that bits of rubber and other detritus were found in vials of five different drugs manufactured at Genzyme's beleaguered Allston Landing plant was worthy of the satirical publication "The Onion"--except that it was true.The picture grew murkier over the weekend, with the...
				<ul>
					<li><a class="source" href="http://www.fiercepharma.com/story/more-plant-problems-genzyme-fix/2009-11-17-0?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0">FiercePharma</a> - More plant problems for Genzyme to fix</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/genzyme-contents-pressure/20849/</guid>
	<dc:creator>The In Vivo Blog</dc:creator>
	<pubDate>Wed, 18 Nov 2009 01:30:00 PST</pubDate>
</item>
<item>
	<title><![CDATA[100 Researchers Ask NIH To Fund Ethics Research]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/100-researchers-nih-fund-ethics/20694/</link>
	<description><![CDATA[
	Dozens of researchers, clinicians, and ethicists sent a letter asking the NIH to fund research on medical ethics, conflicts of interest, and industry influence on prescribing behavior. Why? They note that stimulus funding has increased the NIH budget significantly, but the agency has “no...
				<ul>
					<li><a class="source" href="http://pharmagossip.blogspot.com/2009/11/attention-nih-one-hundred-signatures.html">PharmaGossip</a> - Attention NIH - one hundred signatures</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/100-researchers-nih-fund-ethics/20694/</guid>
	<dc:creator>Pharmalot</dc:creator>
	<pubDate>Tue, 17 Nov 2009 06:08:37 PST</pubDate>
</item>
<item>
	<title><![CDATA[UCB sharpens axe for new round of job cuts]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/ucb-sharpens-axe-job-cuts/21056/</link>
	<description><![CDATA[
	Belgium's UCB is reengineering some of its research operations as it trims two percent of its global workforce. Its research division NewMedicines is being downsized, with 174 positions at its Braine-l'Alleud site in Belgium and 44 positions in Slough, England on the chopping block.   R&D isn't...
				<ul>
					<li><a class="source" href="http://www.in-pharmatechnologist.com/Industry-Drivers/UCB-to-cut-200-jobs-in-UK-and-Belgium?utm_source=RSS_text_news">In-Pharma Technologist</a> - UCB to cut 200 jobs in UK and Belgium</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/ucb-sharpens-axe-job-cuts/21056/</guid>
	<dc:creator>FierceBiotech</dc:creator>
	<pubDate>Tue, 17 Nov 2009 05:51:26 PST</pubDate>
</item>
<item>
	<title><![CDATA[Pioneering deCODE Genetics files for Ch. 11]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/pioneering-decode-genetics-files-ch/20662/</link>
	<description><![CDATA[
	Icelandic genomics pioneer deCODE Genetics has filed for Chapter 11 bankruptcy protection, listing assets close to $70 million and debt of more than $313 million. But it filed papers in court outlining a deal to sell its Icelandic subsidiary to Saga, which is backed by Polaris Venture Partners...
				<ul>
					<li><a class="source" href="http://www.fiercebiotech.com/story/decode-files-ch-11-bankruptcy/2009-11-17?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0">FierceBiotech</a> - DeCODE files for Ch. 11 bankruptcy</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/pioneering-decode-genetics-files-ch/20662/</guid>
	<dc:creator>FierceBioResearcher</dc:creator>
	<pubDate>Tue, 17 Nov 2009 04:25:23 PST</pubDate>
</item>
<item>
	<title><![CDATA[GSK deal draws smokers' vaccine closer]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/gsk-draws-smokers-vaccine/20583/</link>
	<description><![CDATA[
	Smokers may soon be able to break their habit with an injectable vaccine that prevents nicotine in tobacco entering the brain, where it creates a highly addictive sensation of pleasure. The NicVAX vaccine moved closer to the market on Monday after a deal between GlaxoSmithKline and the US biotech...
				<ul>
					<li><a class="source" href="http://www.fiercebiotech.com/story/nabi-scores-540-million-pact-gsk-nicvax/2009-11-16?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0">FierceBiotech</a> - Nabi scores $540 million pact with GSK for NicVAX</li>
					<li><a class="source" href="http://feedproxy.google.com/~r/fastcompany/headlines/~3/C4aX7r__xeM/glaxosmithkline-pays-540-million-nicotine-vaccine">Fast Company</a> - GlaxoSmithKline Signs $540 Million Deal for Nicotine Vaccine</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/gsk-draws-smokers-vaccine/20583/</guid>
	<dc:creator>Financial Times</dc:creator>
	<pubDate>Mon, 16 Nov 2009 14:32:56 PST</pubDate>
</item>
<item>
	<title><![CDATA[Drugmakers vow battle against House bill]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/drugmakers-vow-battle-house-bill/20502/</link>
	<description><![CDATA[
	With the U.S. House version of healthcare reform still moving forward, drugmakers are digging in. They're pledging to fight the House proposals it considers unfriendly to the industry, working closely with lobbyists and pushing back against sales projections that contradict industry talking...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/rl1kXf_yeF4/">Pharmalot</a> - Pharma Will Fight House Health Reform Bill</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/drugmakers-vow-battle-house-bill/20502/</guid>
	<dc:creator>FiercePharma</dc:creator>
	<pubDate>Mon, 16 Nov 2009 08:25:04 PST</pubDate>
</item>
<item>
	<title><![CDATA[FDA: Watch out for tainted Genzyme drugs]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/fda-watch-tainted-genzyme-drugs/20498/</link>
	<description><![CDATA[
	Genzyme just can't seem to catch a break. Vials of five of its meds for rare diseases may be tainted with bits of rubber, steel, or foreign fibers, the FDA said. And while the contamination doesn't seem to be widespread, it does raise more questions about quality control at the company. Genzyme...
				<ul>
					<li><a class="source" href="http://feedproxy.google.com/~r/Pharmalot/~3/BzUKzDmSJZk/">Pharmalot</a> - Genzyme Drugs Contains Bits Of Trash</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/fda-watch-tainted-genzyme-drugs/20498/</guid>
	<dc:creator>FiercePharma</dc:creator>
	<pubDate>Mon, 16 Nov 2009 07:52:42 PST</pubDate>
</item>
<item>
	<title><![CDATA[Niaspan trounces Zetia, spurring debate]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/niaspan-trounces-zetia-spurring-debate/20499/</link>
	<description><![CDATA[
	Well, analysts were right about that much-anticipated cholesterol drug study. Abbott Laboratories' Niaspan pill did indeed beat out Merck's Zetia at unclogging arteries, according to study results presented at the American Heart Association meeting yesterday. Cardiologists expect the data to...
				<ul>
					<li><a class="source" href="http://pipeline.corante.com/archives/2009/11/16/zetia_takes_another_torpedo.php">In the Pipeline</a> - Zetia Takes Another Torpedo</li>
					<li><a class="source" href="http://feeds.washingtonpost.com/click.phdo?i=638e750866a7e897dd49918615eba912">Washington Post</a> - Study questions Vytorin and Zetia in heart disease treatment</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/niaspan-trounces-zetia-spurring-debate/20499/</guid>
	<dc:creator>FiercePharma</dc:creator>
	<pubDate>Mon, 16 Nov 2009 07:34:41 PST</pubDate>
</item>
<item>
	<title><![CDATA[Genentech Puts Words In The Mouths Of Politicians]]></title>
	<link>http://industry.bnet.com/pharma/news-analysis/genentech-puts-words-mouths-politicians/20476/</link>
	<description><![CDATA[
	If some Congressional statements about health care from Republicans and Democrats sounded similar, there was a good reason. Remarks by more than a dozen lawmakers were ghostwritten, in whole or in part, by Washington lobbyists working for Genentech, The New York Times reports. E-mail messages...
				<ul>
					<li><a class="source" href="http://pharmagossip.blogspot.com/2009/11/healthcare-bill-many-spoke-with-one.html">PharmaGossip</a> - Healthcare Bill: Many Spoke With One Voice - Lobbyists’</li>
				</ul><!-- /stories -->
		]]></description>
	<guid>http://industry.bnet.com/pharma/news-analysis/genentech-puts-words-mouths-politicians/20476/</guid>
	<dc:creator>Pharmalot</dc:creator>
	<pubDate>Mon, 16 Nov 2009 05:25:49 PST</pubDate>
</item>
</channel>
</rss>


